China strengthens supervision of antibiotic drug use

Source: Xinhua | March 12, 2017, Sunday |

Online Edition

CHINA'S top health authority has urged tightened supervision over the clinical use of antibiotic drugs to contain drug-resistance strains, according to a circular.

Health departments and medical institutions at all levels should reinforce supervision on antibiotic use and carry out inspections at least twice a year, said a circular issued by the National Health and Family Planning Commission (NHFPC).

The NHFPC encouraged medical institutions to join the efforts to monitor the clinical use of antibiotic drugs and drug-resistant strains to improve the early warning mechanism.

Abuse of antibiotics can give rise to new strains of hardy bacteria that can live and even thrive despite the use of medication.

At present, drug-resistant infections have become a major challenge to global public health, causing the death of 700,000 people and 230,000 newborns worldwide every year.

In August 2016, the NHFPC issued a national action plan to tighten supervision over antibiotic production, sale and use.

Nation

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403号-1
|
互联网新闻信息服务许可证：31120180004
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

China strengthens supervision of antibiotic drug use

Email this to your friend